{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T18:59:39Z","timestamp":1790362779583,"version":"4.1.0"},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","license":[{"start":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T00:00:00Z","timestamp":1789430400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:p>Low-titer group O whole blood is increasingly used in civilian trauma resuscitation and is usually RhD-positive because RhD-negative whole blood is scarce. For RhD-negative patients and patients of unknown RhD type who retain reproductive potential, transfusion of RhD-positive red cells can cause anti-D alloimmunization and place a future pregnancy at risk for hemolytic disease of the fetus and newborn, a harm that may emerge years after the trauma encounter. The ethical and clinical justification for accepting this risk has depended on the idea that whole blood provides a survival advantage large enough to outweigh the possibility of future reproductive harm. However, two recently published randomized trials of prehospital traumatic hemorrhage found no survival advantage for whole blood over component therapy. Reflecting this evidence, RhD-positive whole blood is ethically unjustified for RhD-negative patients with reproductive potential when compatible products are available. The reproductive harm is distinctive in being preventable through product selection, concentrated in patients who cannot consent during resuscitation, and often compounded by limited access to obstetric care. Institutions should default patients with reproductive potential to RhD-negative products when available until the RhD type is confirmed, guarantee standardized and cost-free follow-up when RhD-incompatible transfusion occurs, and ensure ethical standards within trial protocols.<\/jats:p>","DOI":"10.1097\/aog.0000000000006431","type":"journal-article","created":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T20:00:15Z","timestamp":1789502415000},"update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["RhD-Positive Whole Blood for Patients With Reproductive Potential After Two Randomized Trials of Prehospital Trauma Resuscitation"],"prefix":"10.1097","author":[{"given":"Jeremy W.","family":"Jacobs","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeannie","family":"Callum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian D.","family":"Adkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth A.","family":"Abels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheharyar","family":"Raza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deva","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison P.","family":"Wheeler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah S.","family":"Osmundson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M.","family":"Chooljian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Garrett S.","family":"Booth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,9,15]]},"reference":[{"key":"R1-20260925","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/vox.12265","article-title":"Haemolytic disease of the fetus and newborn","volume":"109","author":"de Haas","year":"2015","journal-title":"Vox Sang"},{"issue":"suppl 2","key":"R2-20260925","first-page":"S85","article-title":"A survey of low titer O whole blood use within the trauma quality improvement program registry","volume":"64","author":"Schauer","year":"2024","journal-title":"Transfusion"},{"issue":"suppl 2","key":"R3-20260925","first-page":"S4","article-title":"Ethical considerations in the use of RhD-positive blood products in trauma","volume":"64","author":"Malone","year":"2024","journal-title":"Transfusion"},{"issue":"suppl 2","key":"R4-20260925","first-page":"S100","article-title":"Receipt of RhD-positive whole blood for life-threatening bleeding in female children: a survey in alloimmunized mothers regarding minimum acceptable survival benefit relative to risk of maternal alloimmunization to anti-D","volume":"64","author":"Sherwood","year":"2024","journal-title":"Transfusion"},{"key":"R5-20260925","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1056\/NEJMoa2516043","article-title":"Prehospital whole blood in traumatic hemorrhage - a randomized controlled trial","volume":"394","author":"Smith","year":"2026","journal-title":"N Engl J Med"},{"key":"R6-20260925","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1056\/NEJMoa2602167","article-title":"Prehospital resuscitation with type O whole blood for trauma and hemorrhage","volume":"394","author":"Sperry","year":"2026","journal-title":"N Engl J Med"},{"key":"R8-20260925","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1080\/16078454.2021.1905395","article-title":"Rate of RhD-alloimmunization after the transfusion of RhD-positive red blood cell containing products among injured patients of childbearing age: single center experience and narrative literature review","volume":"26","author":"Yazer","year":"2021","journal-title":"Hematology"},{"issue":"suppl 1","key":"R9-20260925","first-page":"S185","article-title":"Rate of D-alloimmunization in trauma does not depend on the number of RhD-positive units transfused: the BEST collaborative study","volume":"62","author":"Seheult","year":"2022","journal-title":"Transfusion"},{"issue":"suppl 1","key":"R10-20260925","first-page":"S144","article-title":"Anti-D alloimmunization in Rh(D) negative adults with severe traumatic injury","volume":"61","author":"Raval","year":"2021","journal-title":"Transfusion"},{"key":"R11-20260925","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1111\/vox.13249","article-title":"Estimating the risks of prehospital transfusion of D-positive whole blood to trauma patients who are bleeding in England","volume":"117","author":"Cardigan","year":"2022","journal-title":"Vox Sang"},{"key":"R12-20260925","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1111\/vox.13065","article-title":"The risk to future pregnancies of transfusing Rh(D)-negative females of childbearing potential with Rh(D)-positive red blood cells during trauma resuscitation is dependent on their age at transfusion","volume":"116","author":"Seheult","year":"2021","journal-title":"Vox Sang"},{"key":"R13-20260925","doi-asserted-by":"crossref","first-page":"2161215","DOI":"10.1080\/16078454.2022.2161215","article-title":"Not as \u201cD\u201deadly as once thought - the risk of D-alloimmunization and hemolytic disease of the fetus and newborn following RhD-positive transfusion in trauma","volume":"28","author":"Yazer","year":"2023","journal-title":"Hematology"},{"key":"R14-20260925","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1111\/aogs.70195","article-title":"Understanding the consequences of being RhD immunized during pregnancy 10 years after introduction of targeted routine antenatal anti-D prophylaxis: a retrospective nationwide cohort study","volume":"105","author":"Parhamaa","year":"2026","journal-title":"Acta Obstet Gynecol Scand"},{"key":"R15-20260925","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/trf.17209","article-title":"Primum, non nocere: whole blood, prehospital transfusion and anti-D hemolytic disease of the fetus and newborn","volume":"63","author":"O'Brien","year":"2023","journal-title":"Transfusion"},{"key":"R16-20260925","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1111\/trf.17812","article-title":"Rh immune globulin immunoprophylaxis after RhD-positive red cell exposure in RhD-negative patients via transfusion: a survey of practices","volume":"64","author":"Lu","year":"2024","journal-title":"Transfusion"},{"key":"R17-20260925","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.1111\/trf.18465","article-title":"A survey on the use of Rh immune globulin during a nationwide shortage","volume":"65","author":"O'Brien","year":"2025","journal-title":"Transfusion"},{"key":"R18-20260925","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1097\/XCS.0000000000001732","article-title":"Emergent transfusion and hemolytic disease of the fetus and newborn risk mitigation in females of childbearing potential with life-threatening bleeding: a clinical practice guideline","volume":"242","author":"Leeper","year":"2026","journal-title":"J Am Coll Surg"},{"key":"R19-20260925","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1186\/s13063-025-08971-y","article-title":"Trauma resuscitation with low-titer group O whole blood or products: study protocol for a randomized clinical trial (the TROOP trial)","volume":"26","author":"Jansen","year":"2025","journal-title":"Trials"},{"issue":"suppl 1","key":"R21-20260925","first-page":"S15","article-title":"Revisiting whole blood transfusion for the massively bleeding patient: the origins of resistance to change","volume":"66","author":"Bloch","year":"2026","journal-title":"Transfusion"},{"key":"R22-20260925","doi-asserted-by":"crossref","first-page":"529","DOI":"10.7326\/0003-4819-154-8-201104190-00004","article-title":"Systematic review: benefits and harms of in-hospital use of recombinant factor VIIa for off-label indications","volume":"154","author":"Yank","year":"2011","journal-title":"Ann Intern Med"}],"container-title":["Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/AOG.0000000000006431","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T18:02:58Z","timestamp":1790359378000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/AOG.0000000000006431"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,15]]},"references-count":20,"URL":"https:\/\/doi.org\/10.1097\/aog.0000000000006431","relation":{},"ISSN":["0029-7844","1873-233X"],"issn-type":[{"value":"0029-7844","type":"print"},{"value":"1873-233X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,15]]},"assertion":[{"value":"2026-06-26","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-08-13","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}